12 Sept. | 14:00 - 15:30 |
ROOM 7 | |||||||
YOUNGINNOVATION |
|||||||
THE STATE OF RESEARCH COMMUNICATED BY YOUNG RESEARCHERS | |||||||
TT.VII - Technical Multi-Track with Parallel SYMPOSIA | |||||||
Nanomaterials characterization for biomedicine | |||||||
co-organized with University Magna Graecia of Catanzaro | |||||||
in cooperation with SIRTEPS & SITELF | |||||||
Chair: Antonia MANCUSO, University Magna Graecia of Catanzaro | |||||||
The session will delve into the advanced techniques and methodologies essential for the precise characterization of nanomaterials in biomedical applications. As nanomaterials play an increasingly vital role in areas such as drug delivery, diagnostics, and therapeutic development, understanding their physicochemical properties, biocompatibility, and safety profiles is crucial. This session will cover the latest innovations in analytical tools and assays, addressing the challenges of characterizing complex nanomaterials and ensuring their efficacy and safety in clinical settings. Attendees will gain valuable insights into how accurate characterization drives the advancement of nanomedicine. | |||||||
The symposium is part of the SE.I |
|||||||
TT.VII.I.1 SE.I.13.1 |
Introductive Keynote Luigi CALZOLAI - CV European Commission, Joint Research Center (JRC), ISPRA, Italy Characterization and preclinical testing of nanomedicines |
||||||
TT.VII.I.2 SE.I.13.2 |
Anastasia GAGANINA Sapienza University of Rome Detection of anti-SARS CoV-2 antibodies in human serum by means of Bloch surface waves on 1D photonic crystal biochips" |
||||||
TT.VII.I.3 SE.I.13.3 |
Eleonora D'ALESSANDRO - CV Campus Bio-Medico University of Rome Silica-based nanomaterials: design and optimization of in-batch and in-flow processes |
||||||
TT.VII.I.4 SE.I.13.4 |
Marco RANALDI - CV Roma Tre University Preliminary NMR characterization of gold nanorods developed for drug delivery systems in Glioblastoma cells |
||||||
TT.VII.I.5 SE.I.13.5 |
Elena OLIVIERI Roma Tre University Fluorescently labelled gold nanoparticles as promising carrier for multiple sclerosis drugs |
||||||
Back to Fields & Topics | Back to Plan 12 September | ||